Total Credits: .75
Management of Mitral Valve Disease
Alphonse Ambrosia, DO, FACC
Objectives:
Dr. Ambrosia discloses that he is a member of the speakers bureau for the following companies: Boston Scientific, Medtronics Vascular, Philips/Volcano Corp, Novartis.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W. Camelback Rd., Suite 105, Phoenix, AZ 85015, or by email to info@azosteo.org.
Management of Mitral Valve Disease - Handout (1.7 MB) | 17 Pages | Available after Purchase |
Dr. Ambrosia is an interventional cardiologist specializing in coronary artery disease, heart failure, hypertensive heart disease, stroke and carotid artery disease, coronary angiography and angioplasty, carotid angioplasty and stenting, TEE, PFO closure, renal artery angioplasty and stenting, and TAVI procedure.
Dr. Ambrosia is board certified in cardiovascular disease and interventional cardiology and a Fellow of the American College of Cardiology. He received his osteopathic medical degree from the College of Osteopathic Medicine of the Pacific. Dr. Ambrosia practices with Cardiovascular Associates of Mesa.
Dr. Ambrosia has no disclosures.